Dentbird

About Dentbird

Imagoworks Inc., operating under the brand Dentbird, is a Seoul-based company at the forefront of the digital dentistry market, offering an AI-as-a-Service (AIaaS) platform for dental professionals. Founded in 2019 by CEO Young-jun Kim, Imagoworks originated as a spin-off from the Korea Institute of Science and Technology (KIST). Kim, a 3D medical software expert with over two decades of experience, including research at Stanford University and a 10-year tenure at KIST, established the company to modernize the dental prosthesis design process, which was dominated by costly European software.

The company's core offering, Dentbird Solutions, is a web-based, AI-powered Computer-Aided Design (CAD) software that streamlines the creation of dental restorations. This Software as a Service (SaaS) platform is accessible from any web browser, eliminating the need for expensive software installations and specialized hardware. The business model operates on a credit-based system, where users purchase credits to download the final STL crown design files, which are then ready for milling or 3D printing. This approach targets dentists, dental clinics, and dental laboratories globally, aiming to reduce the time and costs associated with producing dental prosthetics like crowns, bridges, and inlays.

Dentbird's key feature is its AI-driven automation. Upon uploading a patient's 3D oral scan data, the platform's AI automatically detects the margin line of the tooth preparation and suggests an optimal prosthetic design in minutes. This significantly reduces a manual process that could otherwise take much longer, allowing clinicians to focus more on patient care and improving overall productivity. The platform also includes Dentbird Cloud for data management and communication between dentists and labs, and is expanding its capabilities to include designs for dentures and full-arch prostheses.

Imagoworks has demonstrated significant growth, securing a total of $29.4 million in funding, including a substantial Series C round. This capital is fueling its global expansion, particularly in the U.S. market, where it has established a subsidiary and acquired a local dental lab. The company serves a worldwide clientele across more than 110 countries and has formed key partnerships, such as a distribution agreement with Ci Medical in Japan, which has a network of 65,000 clinics and labs.